Anticoccidial Drugs Market to Grow with a CAGR of 3.86% through 2029
Technological advancements in drug development are expected
to drive the Global Anticoccidial Drugs Market in the forecast period, 2025-2029.
According
to TechSci Research report, “Anticoccidial Drugs Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2029F”,
the Global Anticoccidial Drugs Market stood at USD 1.34 Billion in 2023 and is
anticipated to grow with a CAGR of 3.86% through 2029. The growing demand for livestock products such as meat, dairy, and eggs is a significant driver behind the expansion of the worldwide market for anticoccidial drugs. There is a critical need to increase food production sustainably to meet the dietary needs of a growing population. The adoption of intensive farming methods, where animals are raised in close proximity, has led to an increased risk of diseases like coccidiosis. Farmers are increasingly turning to anticoccidial drugs to protect their livestock and maintain productivity levels.
Advancements in veterinary medicine and pharmaceuticals have spurred the development of new and improved anticoccidial drugs with enhanced efficacy, safety profiles, and mechanisms of action. Pharmaceutical companies are investing heavily in research and development to introduce innovative formulations such as vaccines, feed additives, and in-feed medications to better combat coccidiosis. These technological advancements have strengthened the global anticoccidial drugs market, providing farmers with a wider range of options to manage and control the disease in their livestock.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Anticoccidial Drugs Market”
The
Global Anticoccidial Drugs Market is segmented into drug class, drug action, animal
type, distribution channel,
regional distribution, and company.
Based
on animal type, companion animals emerged as the fastest growing segment in
the global anticoccidial drugs market in 2023. The market primarily centers on livestock animals, notably poultry, cattle, and swine, which are reared for food production. Anticoccidial drugs are employed in these animals to prevent and manage coccidiosis, a prevalent parasitic ailment impacting their well-being and output. The expansion of this sector can be attributed to various factors, including the escalating demand for meat products, the amplification of farming practices, and the imperative to uphold animal health and welfare standards. With the global population on the rise, the call for meat products is also surging, necessitating efficient and sustainable methods of livestock farming. Intensified farming methods, characterized by high-density animal husbandry, heighten the susceptibility to diseases such as coccidiosis, thus driving the demand for anticoccidial drugs.
Based
on the distribution channel, Veterinary hospitals emerged as the
dominant segment in the global anticoccidial drugs market in 2023. This is due to the fact that veterinary hospitals act as key providers of veterinary care, addressing various medical requirements for animals, such as diagnosing and treating diseases like coccidiosis. They typically maintain a broad inventory of veterinary pharmaceuticals, making them convenient centers for obtaining anticoccidial drugs. Veterinarians at these hospitals can offer expert advice and recommendations regarding the proper utilization of these medications, fostering confidence among pet owners. Therefore, the accessibility, professional knowledge, and comprehensive offerings provided by veterinary hospitals play a significant role in their leading position in the distribution of anticoccidial drugs.
Major companies operating in Global Anticoccidial
Drugs Market are:
·
Vetoquinol SA
·
Zoetis Philippines Inc
·
Phibro Animal Health Corporation
·
Huvepharma, Inc
·
Elanco US Inc.
·
Biochem Pharmaceutical industries Ltd
·
Ceva Sante Animale SA
·
Impextraco NV
·
Boehringer Ingelheim International
GmbH
·
Merck & Co., Inc.
Download Free Sample Report
Customers can also request for 10% free customization on
this report
“The main driver of the Global Anticoccidial Drugs Market is the increasing demand for livestock products, such as meat, dairy, and eggs, to satisfy the dietary requirements of a expanding population. Intensive farming practices, implemented to boost food production, elevate the susceptibility to diseases like coccidiosis, resulting in a heightened demand for effective treatments. Innovations in veterinary medicine have spurred the creation of novel and enhanced anticoccidial drugs, including vaccines and feed additives, thereby fostering market expansion. The heightened prevalence of coccidiosis in livestock due to intensified production systems further amplifies the necessity for these drugs, driving the market's progression”, said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based management consulting firm.
“Anticoccidial
Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast
Segmented By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical
Derivative, Other Drug Classes), By Drug Action (Coccidiostatic,
Coccidiocidal), By Animal Type (Production Animals, Companion Animals), By
Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Other Distribution
Channels) By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global
Anticoccidial Drugs Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global
Anticoccidial Drugs Market.
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300,
New York, United States-
10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com